Q3 2022 13F Holders as of 30 Sep 2022
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
3,173,874
-
Share change
-
-5,312,235
-
Total reported value
-
$3,774,379
-
Price per share
-
$1.19
-
Number of holders
-
37
-
Value change
-
-$5,146,785
-
Number of buys
-
21
-
Number of sells
-
10
Institutional Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q3 2022
As of 30 Sep 2022,
Summit Therapeutics Inc. - COM (SMMT) was held by
37 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
3,173,874 shares.
The largest 10 holders included
VANGUARD GROUP INC, MILLENNIUM MANAGEMENT LLC, BlackRock Inc., MORGAN STANLEY, GEODE CAPITAL MANAGEMENT, LLC, MARSHALL WACE, LLP, BRIDGEWAY CAPITAL MANAGEMENT, LLC, SUSQUEHANNA INTERNATIONAL GROUP, LLP, GOLDMAN SACHS GROUP INC, and UBS Group AG.
This page lists
37
institutional shareholders reporting positions in this security
for the Q3 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.